Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives.
Xiu-Bei ChenSan-Gang WuPublished in: Breast cancer (Dove Medical Press) (2023)
Breast cancer is the most commonly diagnosed cancer and the leading cause of death among female patients, which seriously threatens the health of women in the whole world. The treatments of breast cancer require the cooperation of a multidisciplinary setting and taking tumor load and molecular makers into account. For early breast cancer, breast-conserving surgery with radiotherapy or mastectomy alone remains the standard management, and the administration of adjuvant systemic therapy is decided by the status of lymph nodes, hormone receptors, and human epidermal growth factor receptor-2. For metastatic breast cancer, the goal of treatments is to prolong survival and maintain quality of life. This review will present the current advances and controversies of surgery, chemotherapy, radiotherapy, endocrine therapy, targeted therapy, immunotherapy, gene therapy, and other innovative treatment strategies in early-stage and metastatic breast cancer.
Keyphrases
- metastatic breast cancer
- early stage
- epidermal growth factor receptor
- early breast cancer
- gene therapy
- minimally invasive
- lymph node
- locally advanced
- coronary artery bypass
- healthcare
- sentinel lymph node
- end stage renal disease
- tyrosine kinase
- public health
- breast cancer risk
- mental health
- ejection fraction
- surgical site infection
- papillary thyroid
- childhood cancer
- metabolic syndrome
- squamous cell carcinoma
- rectal cancer
- pregnant women
- type diabetes
- health information
- climate change
- acute coronary syndrome
- young adults
- mesenchymal stem cells
- patient reported
- drug induced